25 October 2011 - The Eli Lilly and Company Foundation (Lilly Foundation) has committed US $30 million in funding to the Lilly MDR-TB Partnership to continue the fight against multi-drug resistant tuberculosis (MDR-TB) – a disease that disproportionately affects developing countries and kills more than 150,000 people each year. The announcement was made ahead of the opening of the 42nd Union World Conference on Lung Health in Lille, France, later this week. (read more)
|
 Nurses expand action, evidence and advocacy
in the fight against tuberculosis
Evan Lee Appointed Vice-President of Lilly's Global Health Programs
Lilly Funds Research on New TB Therapies
Winner of TB Survival Prize 2011 Announced
Images to Stop TB 2011 Winner
Journalists Awarded for Excellence in Reporting on TB
|
 |
HOME
